Oncological Outcomes in Men With Locally Advanced Prostate Cancer Treated With Neoadjuvant ADT and EBRT Followed by Adjuvant Continuous/Intermittent ADT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Oncological Outcomes for Patients With Locally Advanced Prostate Cancer Treated With Neoadjuvant Endocrine and External-Beam Radiation Therapy Followed by Adjuvant Continuous/Intermittent Endocrine Therapy in an Open-Label, Randomized, Phase 3 Trial
Cancer 2020 Jun 23;[EPub Ahead of Print], K Ito, M Kobayashi, M Komiyama, S Naito, K Nishimura, J Yonese, K Hashine, S Saito, G Arai, M Shinohara, N Masumori, N Shimizu, T Satoh, A Yamauchi, T Tochigi, Y Takezawa, H Fujimoto, A Yokomizo, KI Kakimoto, I Fukui, K Karasawa, T Tsukamoto, M Nozaki, M Hasumi, H Ishiyama, M Ohtani, M Kuwahara, M Harada, Y Ohashi, T Kotake, T Kakizoe, K Suzuki, H YamanakaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.